Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease

NCT01055392 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: Lithium Carbonate
DRUG: Placebo

Sponsor

University of Sao Paulo